Dr. Ann Beliën, Chief Executive Officer and Founder at Rejuvenate Biomed, is addressing the underlying biology of aging including mechanisms like mitochondrial health, cell-cell communication and inflammation in order to promote healthy aging. Taking a combination therapy approach, Rejuvenate is using AI-enable drug discovery to address multiple pathways that are involved in aging. Their lead drug candidate is a treatment for sarcopenia with plans to assess impact on other age-related biomarkers. Ann explains, "The biology of aging indeed is being defined by 12 hallmarks. These 12 hallmarks ar ..read more

Dr. Ann Beliën, Chief Executive Officer and Founder at Rejuvenate Biomed, is addressing the underlying biology of aging including mechanisms like mitochondrial health, cell-cell communication and inflammation in order to promote healthy aging. Taking a combination therapy approach, Rejuvenate is using AI-enable drug discovery to address multiple pathways that are involved in aging. Their lead drug candidate is a treatment for sarcopenia with plans to assess impact on other age-related biomarkers. Ann explains, "The biology of aging indeed is being defined by 12 hallmarks. These 12 hallmarks ar ..read more

Eric Olson, COO and Founder of BetterWay™ by Babson Diagnostics™, reports that traditional blood testing is often seen as inconvenient and unpleasant, causing 40% of people to avoid needed blood tests. Babson has developed a more patient-friendly approach to blood collection using a device that fits on the finger and requires a minimum amount of blood. The BetterWay service allows patients or doctors to order tests where blood is drawn at a local pharmacy and samples analyzed at a central lab, providing a quick turnaround with understandable test results.  Eric explains, "Blood testing is ..read more

Eric Olson, COO and Founder of BetterWay™ by Babson Diagnostics™, reports that traditional blood testing is often seen as inconvenient and unpleasant, causing 40% of people to avoid needed blood tests. Babson has developed a more patient-friendly approach to blood collection using a device that fits on the finger and requires a minimum amount of blood. The BetterWay service allows patients or doctors to order tests where blood is drawn at a local pharmacy and samples analyzed at a central lab, providing a quick turnaround with understandable test results.  Eric explains, "Blood testing is ..read more

Marylyn Rigby, President and CEO of Bioceptive, focuses on improving women's health technologies. Bioceptive has developed a cervical suction retractor as an alternative to the 200-year-old cervical tenaculum device used to insert IUDs and perform biopsies and other intrauterine procedures. While current procedures are extremely painful, there has been a lack of innovation in understanding women's pain because women are often described as hysterical, with little clinical data to get to the source of the pain.   Marylyn explains, "I think that also has to do with what modern medicine is ba ..read more

Marylyn Rigby, President and CEO of Bioceptive, focuses on improving women's health technologies. Bioceptive has developed a cervical suction retractor as an alternative to the 200-year-old cervical tenaculum device used to insert IUDs and perform biopsies and other intrauterine procedures. While current procedures are extremely painful, there has been a lack of innovation in understanding women's pain because women are often described as hysterical, with little clinical data to get to the source of the pain.   Marylyn explains, "I think that also has to do with what modern medicine is ba ..read more

Greg Sturmer, Co-Founder and CEO of Elysium Therapeutics, a company with expertise in reducing pain and addressing opioid use disorder and fatal overdose from fentanyl. Elysium has developed O2P, Oral Overdose Protection, a technology that aims to control the impact of opioids and reduce the risk of use disorder or a fatal overdose. SOOPR is a rescue agent designed specifically for overdoses from synthetic opioids, particularly fentanyl, which can last longer and be more potent than traditional opioids. Greg explains, "Anytime there’s an epidemic, you want to control exposure. The tricky bit i ..read more

Greg Sturmer, Co-Founder and CEO of Elysium Therapeutics, a company with expertise in reducing pain and addressing opioid use disorder and fatal overdose from fentanyl. Elysium has developed O2P, Oral Overdose Protection, a technology that aims to control the impact of opioids and reduce the risk of use disorder or a fatal overdose. SOOPR is a rescue agent designed specifically for overdoses from synthetic opioids, particularly fentanyl, which can last longer and be more potent than traditional opioids. Greg explains, "Anytime there’s an epidemic, you want to control exposure. The tricky bit i ..read more

Dr. Boris Reznik, Chairman and CEO of Immorta Bio, was founded to explore longevity and life extension technologies inspired by the discovery that aged cells can be reprogrammed to become younger ones. The company has a cellular rejuvenation platform that uses the patient's cells and senolytic immunotherapy to help the immune system target and remove senescent cells. These approaches aim to leverage the body's natural mechanism for maintaining health and extending the healthspan, not just lifespan. Boris explains, "First of all, let me just touch upon aging because aging perpetually happens on ..read more

Dr. Boris Reznik, Chairman and CEO of Immorta Bio, was founded to explore longevity and life extension technologies inspired by the discovery that aged cells can be reprogrammed to become younger ones. The company has a cellular rejuvenation platform that uses the patient's cells and senolytic immunotherapy to help the immune system target and remove senescent cells. These approaches aim to leverage the body's natural mechanism for maintaining health and extending the healthspan, not just lifespan. Boris explains, "First of all, let me just touch upon aging because aging perpetually happens on ..read more